Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Allergan plc (NYSE:AGN)

202.66
Delayed Data
As of 4:01pm ET
 -7.34 / -3.50%
Today’s Change
184.50
Today|||52-Week Range
256.80
-3.50%
Year-to-Date
What Can We Do Now?
11:37am / GuruFocus News - Paid Partner Content
Centene: Cramer's Top Takeaways
Sep 19 / TheStreet.com - Paid Partner Content
How is the Age-Related Macular Degeneration Space Faring Now?
10:52am / Zacks.com - Paid Partner Content
The Pitney Bowes Transformation: Cramer's Top Takeaways
Sep 19 / TheStreet.com - Paid Partner Content
Adding to Some Longs
Sep 20 / TheStreet.com - Paid Partner Content
Healthcare Trust of America, Marathon Petroleum: 'Mad Money' Lightning Round
Sep 19 / TheStreet.com - Paid Partner Content
Citigroup Still Loves Allergan
Sep 20 / TheStreet.com - Paid Partner Content
Elizabeth Warren Slams Wells Fargo, Equifax: Cramer's Top Takeaways
Sep 19 / TheStreet.com - Paid Partner Content
Morgan Stanley Downgrades Allergan
Sep 20 / TheStreet.com - Paid Partner Content
How Long Can This Rally Run?: Cramer's 'Mad Money' Recap (Monday 9/19/17)
Sep 19 / TheStreet.com - Paid Partner Content

Today’s Trading

Previous close210.00
Today’s open208.05
Day’s range202.60 - 208.50
Volume5,878,871
Average volume (3 months)2,235,768
Market cap$70.2B
Dividend yield1.38%
Data as of 4:01pm ET, 09/21/2017

Growth & Valuation

Earnings growth (last year)+281.42%
Earnings growth (this year)+20.09%
Earnings growth (next 5 years)+15.23%
Revenue growth (last year)-3.32%
P/E ratioNM
Price/Sales5.55
Price/Book0.99

Competitors

 Today’s
change
Today’s
% change
AZNAstraZeneca-0.12-0.36%
LLYEli Lilly and Co+1.31+1.60%
ABTAbbott Laboratories-0.46-0.89%
NVONovo Nordisk-0.05-0.10%
Data as of 4:02pm ET, 09/21/2017

Financials

Next reporting dateNovember 1, 2017
EPS forecast (this quarter)$4.17
Annual revenue (last year)$14.6B
Annual profit (last year)$15.0B
Net profit margin-6.46%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Generic
Chairman, President &
Chief Executive Officer
Brenton L. Saunders
Chief Operating Officer
Robert A. Stewart
Corporate headquarters
Dublin, Dublin

Forecasts